Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study

INTRODUCTION: A post hoc analysis of a double-blind (DB) active control trial and an open-label extension (OLE) study was conducted to evaluate the long-term effects of lurasidone in patients with schizophrenia. METHODS: In the DB trial, patients were randomised to receive lurasidone or risperidone...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Preeya J., Weidenfeller, Christian, Jones, Andrew P., Nilsson, Jens, Hsu, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140059/
https://www.ncbi.nlm.nih.gov/pubmed/33098548
http://dx.doi.org/10.1007/s40120-020-00221-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140059/
https://www.ncbi.nlm.nih.gov/pubmed/33098548
http://dx.doi.org/10.1007/s40120-020-00221-4

Ejemplares similares